Starton Therapeutics

Starton Therapeutics company information, Employees & Contact Information

Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive continuous treatment to live better, longer. Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are the most common blood cancers in the United States. There is no treatment to help people with CLL to stay in remission, and while advances in treatment have provided people with MM a multitude of treatment options, they struggle with long-term tolerance of high doses, which may be more effective but come with a multitude of side effects. Starton’s team of some of the best in clinical development and hematology/oncology have come together to change the fate for people struggling with the impact of their diseases. If dose-related side effects can be reduced and people can tolerate maintenance therapy for decades to help stay in remission, these cancers – which were previously a death sentence – would become more akin to chronic diseases, with a long lifespan and healthy quality of life. Starton is one of the few life sciences companies funded exclusively by individual investors. We have a business model that is lower risk, faster to market and less capital intensive than biotech companies developing medicines from scratch.

Company Details

Employees
13
Founded
-
Address
215 College Rd,
Phone
+1 800 449 5405
Email
co****@****io.care
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Paramus, New Jersey
Looking for a particular Starton Therapeutics employee's phone or email?

Starton Therapeutics Questions

News

Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing - Yahoo Finance

Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing Yahoo Finance

Keith Darragh Joins Starton Therapeutics as Chief Financial Officer - GlobeNewswire

Keith Darragh Joins Starton Therapeutics as Chief Financial Officer GlobeNewswire

Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide) - Yahoo Finance

Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide) Yahoo Finance

Cidnee Vaykovich Named Starton Therapeutics Chief Operating Officer - GlobeNewswire

Cidnee Vaykovich Named Starton Therapeutics Chief Operating Officer GlobeNewswire

Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment - Yahoo Finance

Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment Yahoo Finance

Starton Therapeutics Receives Clinical Trial Authorization - GlobeNewswire

Starton Therapeutics Receives Clinical Trial Authorization GlobeNewswire

Starton Therapeutics Announces Successful Feasibility - GlobeNewswire

Starton Therapeutics Announces Successful Feasibility GlobeNewswire

Starton Therapeutics and Haisco Pharmaceutical Announce an - GlobeNewswire

Starton Therapeutics and Haisco Pharmaceutical Announce an GlobeNewswire

Starton Therapeutics: Announcing Name Change for ChemioCare Inc - GlobeNewswire

Starton Therapeutics: Announcing Name Change for ChemioCare Inc GlobeNewswire

Top Starton Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant